Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,312
Closed -$423K 268
2024
Q3
$423K Buy
1,312
+30
+2% +$9.81K 0.09% 137
2024
Q2
$401K Buy
+1,282
New +$377K 0.09% 134
2021
Q4
Sell
-976
Closed -$208K 185
2021
Q3
$208K Sell
976
-42
-4% -$9.67K 0.09% 169
2021
Q2
$248K Buy
+1,018
New +$250K 0.14% 123

Other funds holding AMGN

Fermata Advisors's AMGN Position: Q4 2024 in Review

Fermata Advisors sold out of Amgen (AMGN) in Q4 2024, closing a stake of 1,312 shares — an estimated $423K sold.

Fermata Advisors first reported a position in AMGN in Q2 2021 and held it in 4 quarters. The position peaked at $423K in Q3 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Fermata Advisors reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Fermata Advisors sold 1,312 Amgen shares in Q4 2024, an estimated $423K.
  • Fermata Advisors first reported a position in Amgen in Q2 2021 and held it in 4 quarters.
  • Fermata Advisors's Amgen position peaked at $423K in Q3 2024.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Fermata Advisors's 13F filing for Q4 2024, filed 15 Jan 2025.